Picture EBD Group Biotech Showcase 2023 San Francisco 650x100px

News > All

Total search results: 6897 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 39 40 41 ... 67 68 69  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Hookipa Biotech AG. (10/18/17). "Press Release: Dr. Jan van de Winkel Joins Hookipa as Chairman of its Board of Directors". Vienna. 2017-10-18
Bruker Corporation. (10/18/17). "Press Release: The Weizmann Institute of Science Installs 15 Tesla Ultra-High Field Preclinical MRI System to Further Accelerate Multidisciplinary Research". Rehovot. 2017-10-18
InSphero AG. (10/18/17). "Press Release: InSphero to Present Novel 3D Human Liver Fibrosis Model at Annual Liver Meeting in Washington, DC". Schlieren. 2017-10-18
Warp Drive Bio, Inc.. (10/16/17). "Press Release: Warp Drive Bio Forms Strategic Collaboration to Advance Novel Classes of Antibiotics to Combat Multi-Drug-Resistant Bacterial Infections". Cambridge, MA. 2017-10-16
Eurofins Scientific. (10/16/17). "Press Release: Eurofins Expands Its Offering in Food Testing with the Acquisition of Institut Nehring". 2017-10-16
Max-Delbrück-Centrum für Molekulare Medizin (MDC). (10/16/17). "Press Release: MDC Receives Funding to Collaborate on Human Cell Atlas". 2017-10-16
Apeiron Biologics AG. (10/13/17). "Press Release: Apeiron Strengthens Management Board with Industry Expert Peter Llewellyn-Davies as New Chief Financial Officer". Vienna. 2017-10-13
InflaRx GmbH. (10/13/17). "Press Release: InflaRx Announces a $ 55M Series D Financing and Investment Round to Foster Its Clinical Stage Complement anti-C5a Development Programs". Jena. 2017-10-13
EBD Group. (10/13/17). "Press Release: BIO-Europe 2017 to Bring 3,800 Life Science Leaders to Berlin November 6–8". Carlsbad, CA & Berlin. 2017-10-13
Roche. (10/13/17). "Press Release: CHMP Recommends EU Approval of Roche’s Alecensa (alectinib) as a First-line Treatment for People with ALK-positive NSCLC". Basel. 2017-10-13
CRISPR Therapeutics AG. (10/13/17). "Press Release: CRISPR Therapeutics Awarded Grant from Friedreich’s Ataxia Research Alliance to Collaborate with University of Alabama at Birmingham on Gene-edited Treatments for Friedrich’s Ataxia". Zug & Cambridge, M 2017-10-13
BioLAGO e. V.. (10/13/17). "Press Release: BioLAGO Cooperates with European Health Networks". Lucerne. 2017-10-13
Codexis, Inc.. (10/12/17). "Press Release: Codexis and Nestlé Health Science Enter into Healthcare-focused Protein Engineering Platform Partnership". Redwood City, CA. 2017-10-12
SepSolve Analytical Ltd.. (10/12/17). "Press Release: SepSolve Analytical Strengthens Marketing Team". 2017-10-12
Eurofins Scientific. (10/12/17). "Press Release: Eurofins to Reinforce Its Forensic Services Portfolio and Footprint with the Acquisition of LGC Forensics". 2017-10-12
Pieris Pharmaceuticals, Inc.. (10/12/17). "Press Release: Pieris Pharmaceuticals Appoints Ingmar Bruns, M.D., Ph.D., as Vice President of Clinical Development". Boston, MA. 2017-10-12
bio.logis Genetic Information Management GmbH. (10/12/17). "Press Release: bio.logis GIM Launches First Version of an iOS Mobile App for Personalized Drug Therapy". 2017-10-12
Qiagen N.V.. (10/12/17). "Press Release: Qiagen Bioinformatics and NGS Solutions Enable Genomic Breakthroughs". Hilden & Germantown, MD. 2017-10-12
Merck KGaA. (10/11/17). "Press Release: Merck Opens New Life Science Center for Scientific Collaboration". Darmstadt. 2017-10-11
MC Services AG. (10/11/17). "Press Release: MC Services AG Welcomes Dr. Claudia Gutjahr-Loeser as New Member of the Management Team". Munich & Dusseldorf. 2017-10-11
Arburg GmbH & Co. KG. (10/11/17). "Press Release: 100th Allrounder Delivered to Eppendorf". Lossburg. 2017-10-11
Evotec AG. (10/10/17). "Press Release: Evotec Achieves First Milestone in Neurodegeneration Alliance with Celgene". Hamburg. 2017-10-10
Optibrium Ltd.. (10/10/17). "Press Release: Optibrium Joins EUR 40 Million eTRANSAFE Project". Cambridge. 2017-10-10
High-Tech Gründerfonds Management GmbH. (10/10/17). "Press Release: The Game Changer in Surgical Education – Breaking Bones for Better Patient Outcomes. Cologne Based MedTech Start-up Rimasys Received Financing from Investor HTGF". 2017-10-10
4SC AG. (10/10/17). "Press Release: Resminostat Demonstrates Potential to Significantly Alleviate Itching in CTCL Patients". Planegg-Martinsried. 2017-10-10
Protea Biosciences Group, Inc.. (10/10/17). "Press Release: Protea Announces Clinical Assay Development Plans. Clinical Assays Will Be developed Using Bruker's MALDI Tissuetyper System". Morgantown, WV. 2017-10-10
BIA Separations d.o.o.. (10/10/17). "Press Release: BIA Separations and Nuvonis Technologies Announce the signing of an Agreement to Collaborate on the Sales and Marketing of Their Technologies and Process Development Know-how". Ajdovšcina & Vienna. 2017-10-10
Qiagen N.V.. (10/9/17). "Press Release: Qiagen and Centogene to Collaborate in Bioinformatics for Genetic Diseases". Hilden, Rostock & Germantown, MD. 2017-10-09
Lonza Group AG. (10/9/17). "Press Release: Lonza Announces Formation of New Research and Development Collaborative Innovation Center in Israel". Basel. 2017-10-09
Wilex AG. (10/9/17). "Press Release: Interim Management Statement for the First Nine Months of 2017". Munich. 2017-10-09
Wilex AG. (10/9/17). "Press Release: Wilex AG Announces Adjustment of Guidance [Ad-hoc release – Insider information pursuant to Article 17 MAR]". Ladenburg. 2017-10-09
Ascenion GmbH. (10/9/17). "Press Release: Medical University Innsbruck Chooses Ascenion as Partner for Enhanced Knowledge and Technology Transfer". Munich. 2017-10-09
Swedish Orphan Biovitrum AB. (10/6/17). "Press Release: Norbert Oppitz Joins Sobi as New Senior Vice President, Specialty Care". 2017-10-06
Cytel Inc.. (10/6/17). "Press Release: Cytel Adds New Basel Location In Continued Expansion". 2017-10-06
Roche. (10/6/17). "Press Release: FDA Approves Roche cobas Zika as First Commercially-available Donor Screening Test for Zika virus". Basel. 2017-10-06
Tecan Group Ltd.. (10/6/17). "Press Release: Tecan Initiates Succession Process for the Board of Directors". Männedorf. 2017-10-06
Bruker Corporation. (10/6/17). "Press Release: Bruker Introduces Additional Key Products for Diagnosis and Susceptibility Testing of Invasive Fungal Diseases (IFD) into European Clinical Microbiology Markets". Belgrade. 2017-10-06
Progen Biotechnik GmbH. (10/5/17). "Press Release: Progen Acquires EuroProxima’s Research Antibodies". Heidelberg. 2017-10-05
Berlin Institute of Health. (10/5/17). "Press Release: Digital Health Accelerator from Berlin Health Innovations Starts with Three Teams". 2017-10-05
ProBioGen AG. (10/5/17). "Press Release: Chiome Bioscience Selects ProBioGen for GlymaxX Antibody Manufacturing Program". Berlin & Tokyo. 2017-10-05
Agena Bioscience, Inc.. (10/05/17). "Press Release: Agena Bioscience Bolsters MassARRAY Insights Reporting Network by Adding N-of-One". San Diego, CA. 2017-10-05
Apogenix AG. (10/5/17). "Press Release: Apogenix Granted Orphan Designation by the European Commission for Asunercept to Treat Myelodysplastic Syndromes". Heidelberg. 2017-10-05
Immatics Biotechnologies GmbH. (10/4/17). "Press Release: Immatics Receives USD 58 Million in Financing to Develop T-Cell Receptor Based Immunotherapies". Tübingen & Houston, TX. 2017-10-04
Berlin Institute of Health. (10/4/17). "Press Release: BIH, Charité and MDC Sign Cooperation Agreement with Sanofi in Germany". 2017-10-04
Precision for Medicine. (10/4/17). "Press Release: Precision for Medicine Acquires Epiontis – a Leading Immune Monitoring and Epigenetic Technology Service Provider". Bethesda, MD & Berlin. 2017-10-04
BioNTech AG. (10/4/17). "Press Release: BioNTech Manufacturing Subsidiary, Eufets, Becomes BioNTech Innovative Manufacturing Services". Mainz. 2017-10-04
Siamab Therapeutics, Inc.. (10/4/17). "Press Release: Siamab Therapeutics and Boehringer Ingelheim Announce Strategic Cancer Immunology Discovery Collaboration to Develop Antibody Therapeutics Targeting Multiple Solid Tumors". Newton, MA. 2017-10-04
InGeneron Inc.. (10/4/17). "Press Release: InGeneron Appoints Angelo Moesslang as Chief Executive Officer". Houston, TX & Munich. 2017-10-04
Rentschler Biopharma SE. (10/4/17). "Press Release: Rentschler Biotechnologie GmbH Announces Transition into a European Corporation Called Rentschler Biopharma SE". Laupheim. 2017-10-04
Lunaphore Technologies S.A.. (10/4/17). "Press Release: Lunaphore Closes a CHF 6M Financing Round". Lausanne. 2017-10-04
Merck KGaA. (10/3/17). "Press Release: Merck Invests € 35 Million in Its Italian Biotech Manufacturing Site of Bari". Bari. 2017-10-03
Noxxon Pharma N.V.. (10/3/17). "Press Release: Noxxon Publishes Preclinical Proof-of-Concept Data for Lead Compound NOX-A12 in Combination with Checkpoint Inhibitors". Berlin. 2017-10-03
Global Bioenergies S.A.. (10/3/17). "Press Release: Global Bioenergies Strengthens Its Management Team". Évry. 2017-10-03
Lonza Group Ltd.. (10/3/17). "Press Release: Lonza to Acquire a U.S. Clinical Manufacturing Site to Support Ongoing Customer Demand". Basel. 2017-10-03
Roche. (10/3/17). "Press Release: Roche Launches Navify Tumor Board Solution to Provide Decision Support to Oncology Care Teams". Basel. 2017-10-03
Gilead Sciences, Inc.. (10/3/17). "Press Release: Gilead Sciences Completes Acquisition of Kite Pharma, Inc.". Foster City, CA. 2017-10-03
Cullinan Oncology, LLC. (10/3/17). "Press Release: Cullinan Oncology Secures $150 Million Series A Financing To Build Innovative Development Company". Cambridge, MA. 2017-10-03
Bruker Corporation. (10/2/17). "Press Release: Bruker Launches the Alpha II, the Second Generation of the World’s Most Popular Compact FTIR System for Chemical Analysis, Applied Markets and Industrial Quality Control". Billerica, MA. 2017-10-02
CRISPR Therapeutics AG. (10/2/17). "Press Release: CRISPR Therapeutics Announces Promotion of Samarth Kulkarni, Ph.D. to Chief Executive Officer". Zug & Cambridge, MA. 2017-10-02
Global Bioenergies S.A.. (10/2/17). "Press Release: Publication of the half-year results to 30/06/2017. Net Loss for the Group of €7.8 Million in the First Half of 2017". Évry. 2017-10-02
Pieris Pharmaceuticals, Inc.. (10/2/17). "Press Release: Pieris Pharmaceuticals Announces Dosing of First Patient in Phase I Trial for Fully Proprietary Lead IO Program, PRS-343". Boston, MA. 2017-10-02
Qiagen N.V.. (10/2/17). "Press Release: Qiagen Achieves ISO Certification for State-of-the-Art Quality in Forensics". Hilden & Germantown, MD. 2017-10-02
Roche. (9/29/17). "Press Release: FDA Grants Priority Review for Roche’s Perjeta (pertuzumab) for Adjuvant Treatment of HER2-positive Early Breast Cancer". Basel. 2017-09-29
Noxxon Pharma N.V.. (9/29/17). "Press Release: Noxxon Supervisory Board Elects Experienced US & EU Biotech Veteran Don deBethizy Chairman". Berlin. 2017-09-29
Novartis AG. (9/28/17). "Press Release: Novartis and UC Berkeley Collaborate to Tackle »Undruggable« Disease Targets". Basel. 2017-09-28
Evotec AG. (9/28/17). "Press Release: Evotec Invests in Exscientia to Advance AI-driven Drug Discovery". Hamburg & Dundee. 2017-09-28
Immatics Biotechnologies GmbH. (9/28/17). "Press Release: Immatics Initiates the First Phase I Clinical Trial of its Unique ACTengine Approach in Patients with Advanced Solid Cancers". Houston, TX & Tübingen. 2017-09-28
Streck, Inc.. (9/28/17). "Press Release: Streck Signs Distribution Agreement with Orgentec SASU". La Vista, NE. 2017-09-28
Roche. (9/28/17). "Press Release: Roche’s Ocrevus (ocrelizumab) Approved in Switzerland for Primary Progressive and Relapsing Forms of Multiple Sclerosis". Basel. 2017-09-28
ThromboGenics N.V.. (9/28/17). "Press Release: ThromboGenics Successfully Introduces New »Already-Diluted« Formulation of Jetrea (ocriplasmin) in the US". Leuven. 2017-09-28
Basilea Pharmaceutica Ltd.. (9/28/17). "Press Release: Basilea Announces License Agreement for Antibiotic Zevtera (ceftobiprole) with Shenzhen China Resources Gosun Pharmaceutical Co., Ltd.". Basel. 2017-09-28
Noxxon Pharma N.V.. (9/28/17). "Press Release: Noxxon Provides Update on Ongoing Phase 1/2 Clinical Trial with Lead Program NOX-A12". Berlin. 2017-09-28
Genedata AG. (9/27/17). "Press Release: Genedata Screener Strengthens Collaborative Research at Axxam". Basel. 2017-09-27
Endress+Hauser AG. (9/27/17). "Press Release: Endress+Hauser Inaugurates New Campus in Lyon". 2017-09-27
Oxford Immunotec Global plc. (9/27/17). "Press Release: Oxford Immunotec Announces Update in Patent Infringement Litigation". Oxford & Marlborough, MA. 2017-09-27
Bruker Corporation. (9/26/17). "Press Release: Bruker Announces Acquisition of Merlin to Add Selected Antibiotic Resistance and Susceptibility Testing to its MALDI Biotyper Microbial Identification Platform". Bremen. 2017-09-26
Juno Therapeutics, Inc.. (9/26/17). "Press Release: Juno Therapeutics Closes Follow-on Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares". Seattle, WA. 2017-09-26
Roivant Sciences GmbH. (9/26/17). "Press Release: Axovant Announces Negative Topline Results of Intepirdine Phase 3 MINDSET Trial in Alzheimer’s Disease". Basel. 2017-09-26
AvroBio, Inc.. (9/26/17). "Press Release: AvroBio, Inc. Appoints Katina Dorton as Chief Financial Officer". Cambridge, MA. 2017-09-26
Novartis AG. (9/22/17). "Press Release: Novartis and The Max Foundation Transform Pioneering Cancer Access Program for People in Lower-income Countries". Basel. 2017-09-22
Juno Therapeutics, Inc.. (9/21/17). "Press Release: Juno Therapeutics Prices $250 Million Follow-on Offering". Seattle, WA. 2017-09-21
Juno Therapeutics, Inc.. (9/21/17). "Press Release: Juno Therapeutics Opens New Headquarters and Research Center". Seattle, WA. 2017-09-21
Humabs BioMed S.A.. (9/21/17). "Press Release: Data on Novel Bi-specific Antibody to Treat Zika Virus Infection Published in »Cell«". 2017-09-21
Abivax S.A.. (9/20/17). "Press Release: Abivax First-half 2017 Financial Results and Update". Paris. 2017-09-20
Roivant Sciences GmbH. (9/20/17). "Press Release: Roivant Sciences Launches Datavant to Improve Clinical Trials with Artificial Intelligence". San Francisco, CA & Basel. 2017-09-20
Novartis AG. (9/20/17). "Press Release: Novartis Drug Rydapt (midostaurin) Receives EU Approval for Newly Diagnosed FLT3-mutated Acute Myeloid Leukemia (AML) and Three Types of Advanced Systemic Mastocytosis (SM)". Basel. 2017-09-20
Nabriva Therapeutics plc. (9/19/17). "Press Release: Nabriva Therapeutics Announces Pricing of Public Offering of Ordinary Shares of Approximately $80 Million". Dublin & King of Prussia, PA. 2017-09-19
Transgene S.A.. (9/19/17). "Press Release: First Patient Treated in a Phase 1b/2 Trial of TG4001 in Combination with Avelumab in HPV-Positive Cancers". Strasbourg. 2017-09-19
Nabriva Therapeutics plc. (9/18/17). "Press Release: Nabriva Therapeutics Announces Proposed Public Offering of Ordinary Shares". Dublin & King of Prussia, PA. 2017-09-18
Nabriva Therapeutics plc. (9/18/17). "Press Release: Nabriva Therapeutics Announces Positive Topline Results from Global, Phase 3 Clinical Trial Evaluating IV and Oral Lefamulin for the Treatment of Community-Acquired Bacterial Pneumonia". Dublin & King 2017-09-18
Roivant Sciences GmbH. (9/18/17). "Press Release: Urovant Sciences Appoints Keith A. Katkin as Chief Executive Officer". Basel. 2017-09-18
Bruker Corporation. (9/18/17). "Press Release: Bruker Launches the timsTOF Pro Mass Spectrometer to Enable the Revolutionary PASEF Method for Next-Generation Proteomics". Dublin. 2017-09-18
ThromboGenics N.V.. (9/18/17). "Press Release: ThromboGenics Regains Global Rights to Jetrea (ocriplasmin)". Leuven. 2017-09-18
High-Tech Gründerfonds Management GmbH. (9/18/17). "Press Release: Evonik Is Investing in Numaferm, a Specialist in the Biotechnological Production of Peptides". 2017-09-18
Ncardia. (9/18/17). "Press Release: Ncardia Established Following Pluriomics Axiogenesis Merger". Gosselies, Cologne, Leiden & Philadelphia, PA. 2017-09-18
Tolremo Therapeutics AG. (9/18/17). "Press Release: Tolremo Therapeutics AG – Preventing Drug Resistance in Cancer Therapy". Zürich. 2017-09-18
Bayer AG. (9/15/17). "Press Release: Bayer Receives Positive CHMP Opinion for Rivaroxaban 10 mg Once Daily for the Extended Prevention of Venous Thromboembolism [Not intended for U.S. and UK Media]". Berlin. 2017-09-15
Selexis S.A.. (9/15/17). "Press Release: Selvita Demonstrates Strong Revenue Growth in H1 2017". Kraków. 2017-09-15
Santhera Pharmaceuticals Holding AG. (9/15/17). "Press Release: Santhera Receives Negative Opinion from the CHMP for Its Marketing Authorization Application for Raxone in DMD and Intends to Appeal this Opinion". Liestal. 2017-09-15
Boehringer Ingelheim. (9/15/17). "Press Release: Boehringer Ingelheim Receives Positive CHMP Opinion for Adalimumab Biosimilar Cyltezo". Ingelheim. 2017-09-15
next pagenext page 1 2 3 ... 39 40 41 ... 67 68 69  next pagenext page


Picture [iito] Fighting Customers 650x100px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at (European life sciences) and (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at (life sciences in German-speaking Europe) and (worldwide mass spectrometry)


Picture Campus Berlin-Buch GmbH GMP Basic Course Online 650x300px

» top